** Shares of IDT Australia IDT.AX rise as much as 8.7% to
A$0.125
** Shares on track for their best day since July 12, if
gains hold
** The pharma manufacturer secures contract with Sanofi
Australia for pre-clinical formulation, development and
manufacture of Sanofi's messenger RNA technology for its
translational clinical programme
** Co says contract worth between A$2.5 mln and A$4 mln
(($1.65 mln and $2.64 mln)
** Stock has risen 7.3% this year, as of last close
($1 = 1.5172 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))